UnitedHealth Group
UNH | NYSE
$375.65
-$1.25 (-0.33%)
Sep 21, 2026, 12:49 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 447.57B | 400.28B | 371.62B | 324.16B | 287.6B | 257.14B |
Cost of Revenue | 364.65B | 310.88B | 280.66B | 244.55B | 217.95B | 190.14B |
Gross Profit | 82.92B | 89.4B | 90.96B | 79.62B | 69.65B | 67B |
Operating Income | 18.96B | 32.29B | 32.36B | 28.44B | 23.97B | 22.41B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 14.7B | 20.07B | 29.11B | 26.34B | 22.31B | 20.74B |
Net Income | 12.06B | 14.41B | 22.38B | 20.12B | 17.29B | 15.4B |
Selling & General & Admin | n/a | n/a | n/a | n/a | n/a | n/a |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 63.95B | 57.11B | 58.6B | 51.18B | 45.68B | 44.6B |
Operating Expenses | 63.95B | 57.11B | 58.6B | 51.18B | 45.68B | 44.6B |
Interest Expense | 4B | 3.91B | 3.25B | 2.09B | 1.66B | 1.66B |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 428.6B | 367.99B | 339.26B | 295.73B | 263.63B | 234.74B |
Income Tax Expense | 1.89B | 4.83B | 5.97B | 5.7B | 4.58B | 4.97B |
Shares Outstanding (Basic) | 910M | 929M | 928M | 934M | 943M | 946M |
Shares Outstanding (Diluted) | 910M | 929M | 938M | 950M | 956M | 961M |
EPS (Basic) | 13.23 | 15.64 | 24.12 | 21.54 | 18.33 | 16.28 |
EPS (Diluted) | 13.23 | 15.51 | 23.86 | 21.18 | 18.08 | 16.03 |
EBITDA | 23.06B | 28.08B | 36.33B | 31.84B | 27.07B | 25.3B |
EBIT | 18.7B | 23.98B | 32.36B | 28.44B | 23.97B | 22.41B |
Depreciation & Amortization | 4.36B | 4.1B | 3.97B | 3.4B | 3.1B | 2.89B |
Add to Watchlist
Select watchlists to add or remove UNH